These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33198757)

  • 21. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of RNA-binding proteins in human colorectal cancer.
    Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
    World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.
    Lv J; Li L
    Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
    Makondi PT; Chu CM; Wei PL; Chang YJ
    PLoS One; 2017; 12(7):e0180616. PubMed ID: 28749961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Hub Genes in Different Stages of Colorectal Cancer through an Integrated Bioinformatics Approach.
    Patil AR; Leung MY; Roy S
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.
    Manoochehri H; Jalali A; Tanzadehpanah H; Taherkhani A; Saidijam M
    J Gastrointest Cancer; 2022 Sep; 53(3):649-668. PubMed ID: 34432208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Potential Key Genes and Pathways in Early-Onset Colorectal Cancer Through Bioinformatics Analysis.
    Zhao B; Baloch Z; Ma Y; Wan Z; Huo Y; Li F; Zhao Y
    Cancer Control; 2019; 26(1):1073274819831260. PubMed ID: 30786729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer.
    Qi Y; Qi H; Liu Z; He P; Li B
    J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer.
    Iman M; Mostafavi SS; Arab SS; Azimzadeh S; Poorebrahim M
    Recent Pat Anticancer Drug Discov; 2016; 11(4):434-443. PubMed ID: 27855613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genes associated with inflammation may serve as biomarkers for the diagnosis of coronary artery disease and ischaemic stroke.
    Zheng PF; Liao FJ; Yin RX; Chen LZ; Li H; Nie RJ; Wang Y; Liao PJ
    Lipids Health Dis; 2020 Mar; 19(1):37. PubMed ID: 32164735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
    Huang C; Li R; Shi W; Huang Z
    Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
    Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
    Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
    Guo T; Hou D; Yu D
    Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.